TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

NCT02663271 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped stagnant enrollment

Conditions

Glioblastoma Multiforme
Glioblastoma
Malignant Glioma
GBM

Interventions

DRUG: Bevacizumab
DEVICE: Optune
OTHER: Brain MRI
OTHER: Quality of Life Questionnaires

Sponsor

University of Florida

Collaborators

[object Object]